SCHEMBL5127180

SCHEMBL5127180

CCC(C(=O)O)c1cc(S(=O)(=O)NC)cc2ccccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ TSHR P16473 1/20 0.41
▸ NQO2 P16083 1/20 0.39
▸ MTNR1A P48039 1/20 0.39
▸ RORC P51449 1/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ PKM P14618 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ TDP1 Q9NUW8 2/20 0.36
▸ SLC1A3 P43003 1/20 0.36
▸ SLC1A2 P43004 1/20 0.36
▸ SLC1A1 P43005 1/20 0.36
▸ AKR1C3 P42330 1/20 0.36
▸ AKR1C2 P52895 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ ALDH1A1 P00352 4/20 0.35
▸ KAT6A Q92794 1/20 0.35
▸ NR3C2 P08235 1/20 0.35
▸ G6PD P11413 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29272525 0.76 MEN1 (0.44) MEN1KMT2AAKR1C3AKR1C2ALDH1A1
SCHEMBL1669621 0.75 CNR2 (0.41) SMN1; SMN2MEN1KMT2AAKR1C3AKR1C2
SCHEMBL7831310 0.75 L3MBTL1 (0.53) L3MBTL1TSHRSMN1; SMN2MEN1PKM
SCHEMBL447136 0.74 CYP2C9 (0.48) TSHRTDP1ALDH1A1
SCHEMBL7831361 0.71 L3MBTL1 (0.51) L3MBTL1TSHRNQO2MTNR1ASMN1; SMN2
SCHEMBL29439167 0.71 AKR1C3 (0.44) MTNR1ASMN1; SMN2MEN1KMT2AAKR1C3
SCHEMBL7837993 0.70 KDM4E (0.50) L3MBTL1TSHRMEN1KMT2ATDP1
SCHEMBL7604547 0.70 ACP3 (0.40) AKR1C3AKR1C2POLBALDH1A1
SCHEMBL599642 0.70 CYP2C9 (0.43) TSHRTDP1ALDH1A1
SCHEMBL10918666 0.69 AKR1C3 (0.43) MEN1KMT2AAKR1C3AKR1C2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8580965-B2 Substituted sulfonamide compounds GRUENENTHAL GMBH (DE) 2013-11-12 — — US disclosed
US-20080249128-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2008-10-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249128-A1 Substituted Sulfonamide Compounds BDKRB1, BDKRB2, NPSR1 L3MBTL1 3720/4885TSHR 645/4885NQO2 3158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback